Humana Inc.’s Stock Price Takes a Dive, Falling 3.46% to 284.82 USD

Humana Inc. (HUM)

284.82 USD -10.22 (-3.46%) Volume: 1.47M

Humana Inc.’s stock price is currently standing at 284.82 USD, experiencing a drop of -3.46% this trading session with a trading volume of 1.47M. Despite the daily downturn, HUM’s YTD performance remains positive with a gain of +12.26%, reflecting the company’s robust financial health in the market.

Latest developments on Humana Inc.

Humana Inc. (NYSE:HUM) has seen significant market moves recently, with Jim Cramer cheering the company’s performance. Ceeto Capital Group LLC and the Treasurer of the State of North Carolina have both purchased shares of Humana Inc., while FIL Ltd, Legal & General Group Plc, and O Shaughnessy Asset Management LLC have sold off portions of their holdings. Various other investment firms such as APG Asset Management US Inc., Monetary Management Group Inc., and CenterBook Partners LP have stakes in Humana Inc. as well. In contrast, Sterling Capital Management LLC, Neuberger Berman Group LLC, and Fmr LLC have reduced their positions. Overall, Invesco Ltd. holds a significant $608.35 million in stock holdings in Humana Inc. while Aviva PLC, Bank of Montreal Can, and Bank of Nova Scotia have also made moves in their stakes. Jim Cramer’s positive outlook on Humana Inc. comes amidst these diverse market activities.

Humana Inc. on Smartkarma

Analysts on Smartkarma have been closely following Humana Inc, a company that provides Medicare Advantage plans to around 6 million members. Value Investors Club published a bullish report on Monday, Oct 28, 2024, highlighting the company’s focus on value-based care relationships with providers and cost-saving behavior. The report emphasizes Humana’s aim to offer efficient and high-quality care through Medicare Advantage plans, which incentivize preventative treatment and pay for outcomes rather than volume of services provided.

Another bullish report from Baptista Research suggests that Humana could be the next major acquisition target for Cigna, a rival in the U.S. health insurance market. The report mentions informal talks between the two companies, indicating a potential acquisition deal in the works. This news comes at a time when Humana is facing challenges with changes in the government’s Medicare plan ratings, impacting its performance in the market.

A look at Humana Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. is positioned well for the long-term based on its Smartkarma Smart Scores. With high scores in Value and Dividend, the company shows strong fundamentals and potential for steady returns for investors. Additionally, its Momentum score indicates positive market sentiment and potential for growth in the future. While Growth and Resilience scores are slightly lower, the overall outlook for Humana Inc. remains positive.

As a managed health care company, Humana Inc. offers coordinated health care services to a wide range of customers in the United States and Puerto Rico. With a focus on providing quality care through various health plans, the company serves employer groups, government-sponsored plans, and individuals. This diverse customer base, coupled with its strong Smart Scores, positions Humana Inc. as a solid investment choice for those looking for stability and growth in the healthcare sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma